Introduction
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
This supplement of Pediatric Diabetes is the compendium of guidelines chapters published 2006–2008 as individual articles in Pediatric Diabetes, which are available on ISPAD's website www.ispad.org. The guidelines have been modified and updated to reflect major new evidence published since they were published previously. In 2007, the total child population of the world (0–14 years) was estimated to be 1.8 billion, of whom 0.02% have diabetes. This means that approximately 440,000 children around the world have diabetes with 70,000 new cases diagnosed each year 1. However, field data would suggest that some individual country estimates (especially in Africa) are over-estimated. This very large number of children need help to survive with injections of insulin to live a full life without restrictions or disabling complications and without being stigmatized for their diabetes. Even today, almost a century after the discovery of insulin, the most common cause of death in a child with diabetes from a global perspective is lack of access to insulin 2. Many children die before their diabetes is diagnosed. It is therefore of utmost importance that all forces unite to make it come true that no child should die from diabetes. A promising initiative has been taken by IDF/Life for a Child (www.lifeforachild.org) in collaboration with ISPAD and other organizations (Access to Essential Diabetes Medicines for Children in the Developing World). Several major companies that produce insulin and other diabetes supplies have pledged their support, and the numbers of children provided with insulin will according to plan increase to approximately 12,000 in 2010 and 30,000 by 2015. ISPAD has pledged structural support and assistance in the training of paediatricians and healthcare professionals in childhood and adolescent diabetes through its membership network. In 1993, members of the International Society for Pediatric and Adolescent Diabetes (ISPAD) formulated the Declaration of Kos, proclaiming their commitment to "promote optimal health, social welfare and quality of life for all children with diabetes around the world by the year 2000." Although all the aims and ideals of the Declaration of Kos had not been reached by 2000, we feel that slowly, by small steps, the worldwide care of children is improving. ISPAD published its first set of guidelines in 1995 3 and its second in 2000 4. Since then, the acceptance of intensive therapy, also for very young children, has increased around the world. Insulin pump usage has risen in all age groups in countries where this treatment modality can be afforded. Intensive therapy requires better and more comprehensive education for it to be successful. The ISPAD Consensus Guidelines 2000 has been translated into 11 languages, indicating the need for a truly international document. In 2003–2005, national guidelines for childhood diabetes have been released: the Australian Clinical Practice Guidelines from the National Health and Medical Research Council, (Writing Committee Chair, Martin Silink) 5; in the United Kingdom, the National Institute for Clinical Excellence (NICE) Clinical Guideline (Group Leader Stephen Greene) 6. Both these publications are truly evidence-based in that they deal with the body of evidence with a systematic approach, grading each reference and building the case for each recommendation. In 2003 the Canadian Diabetes Association published Clinical Practice Guidelines with chapters both on type 1 and type 2 in children and adolescents 7. In 2005, the American Diabetes Association (ADA) published their statement on the care of children and adolescents with type 1 diabetes 8. This updated third edition of ISPAD's Consensus Guidelines, now Clinical Practice Consensus Guidelines is much larger, and has been enriched by the above mentioned national guidelines. In the Introduction to the 2000 ISPAD Guidelines the acknowledged intention was for the next guidelines to be referenced. We have used the ADA grading system for grading evidences 9. Whenever possible, the reference for a statement or recommendation has been included, but as the reader will see, a vast majority of the recommendations and suggestions do have the grade E (Expert consensus or clinical experience). The updated 2009 guidelines are based on a wide consensus of clinical practice. They were drafted by international writing teams, modified by experts in different specialties from many countries, debated at the annual ISPAD meetings in 2005–2008 by the members, and were reviewed by members via the Internet and the ISPAD website. As far as possible, significant input by individuals has been acknowledged. Many thanks to the large number of individuals who have contributed but whose names could not be included. The American Diabetes Association evidence grading system for clinical practice recommendations is as follows: As the 2000 Guidelines, the 2006–2008 Guidelines and the 2009 Compendium places education at t
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Care of Children and Adolescents With Type 1 Diabetes
Silverstein, J., Klingensmith, G., Copeland, K., Plotnick, L., Kaufman, F., Laffel, L., Deeb, L., Grey, M., Anderson, B., Holzmeister, L. A., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.186 · Cited by 1,312 · cited 1×
“In 2005, the American Diabetes Association (ADA) published their statement on the care of children and adolescents with type 1 diabetes (8).”
BackgroundSelf-citationGale, E. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69672-4 · Cited by 41 · cited 1×
“Even today, almost a century after the discovery of insulin, the most common cause of death in a child with diabetes from a global perspective is lack of access to insulin (2).”
Background
Cited by
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.gl · Cited by 629
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
Handelsman, Y., Mechanick, J. I., Blonde, L., Grunberger, G., Bloomgarden, Z. T., Bray, G. A., Dagogo-Jack, S., Davidson, J. A., Einhorn, D., Ganda, O., et al. (2011) · Endocrine Practice · doi:10.4158/ep.17.s2.1 · Cited by 513
Diabetic retinopathy management guidelines
Chakrabarti, R., Harper, C. A., & Keeffe, J. E. (2012) · Expert Review of Ophthalmology · doi:10.1586/eop.12.52 · Cited by 112
Metadata
- Authors
- Hanas, R., Donaghue, K. C., Klingensmith, G., & Swift, P. G. F.
- Venue
- Pediatric Diabetes
- Publisher
- Wiley
- Published
- 2009-09
- Volume
- 10
- Pages
- 1-2
- ISSN
- 1399-543X (ISSN-L)
- 1399-5448
- OpenAlex
- W2410777433
- Cited by
- 57
- References
- 2
- FWCI
- 3.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Introduction. https://app.cochat.ai/papers/10.1111/j.1399-5448.2009.00577.x
- The paper
- Hanas, R., Donaghue, K. C., Klingensmith, G., & Swift, P. G. F. (2009). Introduction. Pediatric Diabetes. https://doi.org/10.1111/j.1399-5448.2009.00577.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.